FMS (Fresenius Medical Care AG) Tariff Resilience Score: 5/10 (As of Jun. 26, 2026)


FMS Fresenius Medical Care AG FMS
72 GF Score
Price $23.24
GF Value $24.15
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Tariff Resilience Score?

Fresenius Medical Care AG FMS -0.04% 72 Tariff Resilience Score is 5 as of Jun. 26, 2026. GuruFocus rates FMS with a GF Score™ of 72/100 and a GF Value™ of $24.15 (Fairly Valued). The stock has 4 warning signs investors should review. Among 677 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks better than 79.32% on this metric.

Fresenius Medical Care AG has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Fresenius Medical Care AG has Fresenius Medical Care has a global supply chain and significant international sales. It faces tariff risks on medical equipment imports but benefits from some industry-specific exemptions. Mitigation includes alternative suppliers and strong market presence.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Fresenius Medical Care AG might have Average Resilient.

Fresenius Medical Care AG  (NYSE:FMS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Fresenius Medical Care AG Tariff Resilience Score Related Terms

FMS vs HCA, THC, DVA: Tariff Resilience Score Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius Medical Care AG Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Tariff Resilience Score falls into.


FMS
72GF Score
Fresenius Medical Care AG FMS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Fresenius Medical Care AG (FMS) has a Tariff Resilience Score of 5 as of Jun. 26, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Fresenius Medical Care AG ranks #140 out of 677 companies in the Healthcare Providers & Services industry, placing it in the top 20.7%.
Is Fresenius Medical Care AG's Tariff Resilience Score too high?
Fresenius Medical Care AG's current Tariff Resilience Score is 5. Based on the distribution chart, Fresenius Medical Care AG ranks #140 out of 677 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fresenius Medical Care AG has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Tariff Resilience Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #140 out of 677 companies for Tariff Resilience Score. This places Fresenius Medical Care AG in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Fresenius Medical Care AG's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMS) is currently considered Fairly Valued. The stock's GF Value™ is $24.15, compared to a current price of $23.24 — trading 3.8% below its estimated fair value. The current Tariff Resilience Score is 5. Fresenius Medical Care AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Fresenius Medical Care AG (FMS), the current Tariff Resilience Score is 5 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (FMS) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of $23.24 is trading 3.8% below its estimated GF Value™ of $24.15. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for FMS:

  • Tariff Resilience Score: 5
  • GF Value™: $24.15 vs. price of $23.24 (3.8% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the FMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
72GF Score

Get the complete analysis for FMS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.24
Price
$24.15
GF Value